Skip to main content
. 2020 Nov 23;19(1):201–208. doi: 10.1111/vco.12661

FIGURE 1.

FIGURE 1

A, Kaplan–Meier progression‐free survival of the 55 canine patients with nDLBCL stratified according to the presence or absence of B‐symptoms: Presence of B‐symptoms was an independent predictor of inferior time to progression/tumour recurrence (P = .001). B, Kaplan–Meier lymphoma specific survival of the 55 canine patients with nDLBCL stratified according to the presence or absence of B‐symptoms: Presence of B‐symptoms was an independent predictor of inferior survival (P = .001)